Overview
U.S. tobacco harm reduction firm's Q4 revenue fell 12% yr/yr, losses narrowed
Adjusted EBITDA loss for Q4 improved to $2.4 mln from $3.9 mln yr/yr
Company ended 2025 debt-free with $7.1 mln in cash
Outlook
Company prioritizes expanding VLN retail distribution and consumer awareness in 2026
22nd Century aims to scale toward profitability and maintain engagement with FDA and public health stakeholders
Result Drivers
PRODUCT MIX SHIFT - Co said strategic pivot toward higher-margin proprietary branded products and expanded retail partnerships drove results
VLN DISTRIBUTION EXPANSION - Increased store counts and state authorizations for VLN and partner brands expanded market access
PRODUCT RETURNS AND MIX - VLN cigarette revenues were offset by customer returns and product exchanges tied to new branding, while filtered cigar revenues declined due to shifting product mix
Company press release: ID:nGNX2NhX13
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Net Income |
| -$2.80 mln |
|
Q4 Adjusted EBITDA |
| -$2.39 mln |
|
Q4 Operating Expenses |
| $2 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the tobacco peer group is "buy"
Wall Street's median 12-month price target for 22nd Century Group Inc is $135.00, about 4,003.3% above its March 25 closing price of $3.29
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.